PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of paliperidone extended-release (ER)
in participants with schizophrenia (psychiatric disorder with symptoms of emotional
instability, detachment from reality, often with delusions and hallucinations, and withdrawal
into the self).